DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

18.41 0.37 (2.05%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

HALO $18.41 2.05%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $17.86
Previous Close $18.04
Daily Range $17.84 - $18.55
52-Week Range $7.51 - $25.25
Market Cap $2.4B
P/E Ratio -58.19
Dividend (Yield) $0.00 (0.0%)
Volume 1,285,045
Average Daily Volume 1,542,790
Current FY EPS -$0.40




Drug Makers

Halozyme Therapeutics, Inc. (HALO) Description

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets. Website:

News & Commentary

Should Your Portfolio Say Hello to Halozyme Therapeutics Inc.?

This small-cap biotech has been crushing the markets for years. Does it deserve a place in your portfolio?

Oversold Conditions For Halozyme Therapeutics (HALO)

Today's Dead Cat Bounce Stock Is Halozyme Therapeutics (HALO)

Market Is Poised To Rally - Cramer's Mad Money (8/12/15)

Jim Cramer Advises His Viewers On Halozyme Therapeutics, CF Industries And Tower International

Why Halozyme Shares Jumped 10% Today

Halozyme's new financial guidance suggests it's in good shape to support its clinical development pipeline.

Halozyme (HALO) Stock Spikes Following Earnings Release

Strong On High Relative Volume: Halozyme Therapeutics (HALO)

Halozyme Therapeutics' (HALO) CEO Helen Torley on Q2 2015 Results - Earnings Call Transcript

Halozyme Therapeutics (HALO) Showing Signs Of A Dead Cat Bounce Today

See More HALO News...

HALO's Top Competitors

HALO $18.41 (2.05%)
Current stock: HALO
AMGN $155.89 (0.11%)
Current stock: AMGN
GILD $107.78 (-0.19%)
Current stock: GILD
CELG $124.04 (0.81%)
Current stock: CELG